We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 304.00
Bid: 301.00
Ask: 309.00
Change: 12.00 (4.11%)
Spread: 8.00 (2.658%)
Open: 309.00
High: 309.00
Low: 301.00
Prev. Close: 292.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

16 Mar 2017 16:31

RNS Number : 7386Z
Microgen PLC
16 March 2017
 

16 March 2017

 

MICROGEN plc (the "Company")

 

Director/PDMR Shareholding / Total Voting Rights

 

Microgen plc (LSE: MCGN), a leading provider of business critical software and services, provides notification that on 16 March 2017, following the exercise by a number of the Company's Executive Directors of options under the Microgen Plc Performance Share Plan 2006 ("PSP"), 780,618 new ordinary shares of 6 3/7 pence each in the Company ("Ordinary Shares") have been issued. The issued Ordinary Shares were admitted to the Official List of the UKLA and to trading on the main market of the London Stock Exchange on 25 November 2016.

 

Each of the Executive Directors named below exercised options over the number of Ordinary Shares specified below on 16 March 2017 with an exercise price per Ordinary Share of £0.05. The options had an expiry date of 18 November 2023.

 

Following the exercise of these options each Executive Director's overall shareholding in the Company has increased as set out in the following table. Each Executive Director also sold a number of the resulting Ordinary Shares on 16 March 2017 at a price of £2.70 per Ordinary Share, as set out below.

 

Name of Executive Director

No. of Options Exercised

No. of Ordinary Shares sold

No. of Ordinary Shares held prior to transactions

Number of Ordinary Shares held after transactions

 

Percentage of the issued share capital of the Company held prior to transactions

Percentage of the issued share capital of the Company held after transactions

Tom Crawford (CEO, Aptitude Software)

140,206

69,757

309,551

380,000

0.52%

0.63%

Simon Baines (CEO, Microgen Financial Systems)

320,206

229,729

9,523

100,000

0.02%

0.16%

Philip Wood (Chief Financial Officer)

320,206

230,841

110,635

200,000

0.18%

0.33%

 

In accordance with DTR 5.6.1, the Company also announces that, following the transactions referred to above, as at today's date, its issued share capital comprises 60,771,938 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. The voting rights of all of the Ordinary Shares are identical. Shareholders may use this figure as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, Ordinary Shares in Microgen under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

 

The notification below, made pursuant to Article 19 of Regulation (EU) No 596/2014 on Market Abuse, provides further information about these transactions.

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

(a)

Name

(i) Tom Crawford

(ii) Simon Baines

(iii) Philip Wood

 

2

Reason for the notification

 

(a)

Position/Status

(i) PDMR - (Chief Executive Officer, Aptitude Software)

(ii) PDMR - (Chief Executive Officer, Microgen Financial Systems)

(iii) PDMR - (Chief Financial Officer)

 

(b)

Initial notification / Amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

(a)

Name

Microgen Plc

 

(b)

LEI

2138009VHA1WI2VKMA28

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the financial instrument, type of instrument

 

Identification Code

 

Ordinary Shares of 6 3/7 pence each

 

 

ISIN: GB00BVVHWX30

(b)

Nature of the transaction

 

(a) Exercise of options over Ordinary Shares

(b) Sale of Ordinary Shares

 

(c)

Price(s) and volume(s)

 

Name

(a) Exercise Price per Ordinary Share

(a) Number of Ordinary Shares over which Options Exercised

(b) Sale Price per Ordinary Share

(b) Number of Ordinary Shares sold

(i) Tom Crawford

£0.05

140,206

£2.70

69,757

(ii) Simon Baines

£0.05

320,206

£2.70

229,729

(iii) Philip Wood

£0.05

320,206

£2.70

230,841

(d)

Aggregated Information

- Aggregated Volume

- Price

n/a

(e)

Date of the Transaction

16 March 2017

 

(f)

Place of the Transaction

(a) Outside a trading venue

(b) London Stock Exchange (XLON)

 

Name of authorised official of issuer responsible for making notification:

Mark Heather, Company Secretary, Microgen Plc

 

Contacts

Mark Heather, Company Secretary 020-7496-8100

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGGUMPWUPMGQQ
Date   Source Headline
24th Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSNotice of 2024 Annual General Meeting
8th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20241:46 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:01 amRNSAptitude to Accelerate Autonomous Finance
21st Mar 20247:01 amRNSShare buyback programme
21st Mar 20247:00 amRNSAudited Results for Year Ended 31 December 2023
21st Feb 20247:00 amRNSChange of Broker Arrangements
9th Feb 20247:00 amRNSHolding(s) in Company
31st Jan 20247:00 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSFull Year Trading Update and Notice of Results
4th Jan 20247:00 amRNSFynapse Win
30th Nov 20237:00 amRNSAppointment of Chief Executive Officer
12th Oct 20237:00 amRNSHolding(s) in Company
2nd Oct 20232:17 pmRNSGrant of awards
29th Sep 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
21st Sep 20232:28 pmRNSHolding(s) in Company
20th Sep 20239:32 amRNSHolding(s) in Company
7th Sep 202310:15 amRNSGrant of Awards under Performance Share Plan
23rd Aug 20231:21 pmRNSHolding(s) in Company
23rd Aug 20231:15 pmRNSHolding(s) in Company
28th Jul 202312:18 pmRNSHolding(s) in Company
28th Jul 20237:00 amRNSHolding(s) in Company
27th Jul 20231:52 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSInterim Results
24th Jul 20235:22 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSHolding(s) in Company
19th Jul 20237:00 amRNSDirector Retirement
13th Jul 20237:00 amRNSTrading Update and Directorate Changes
23rd Jun 20234:43 pmRNSHolding(s) in Company
16th Jun 20234:22 pmRNSHolding(s) in Company
25th May 20235:22 pmRNSDirector/PDMR Shareholding
24th May 202311:01 amRNSHolding(s) in Company
23rd May 20236:10 pmRNSDirector/PDMR Shareholding
23rd May 20233:27 pmRNSHolding(s) in Company
17th May 202311:24 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.